Business
Press Release Mar 09 2023
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 09, 2023, titled "Alembic Pharmaceuticals receives USFDA Tentative Approval for Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg.".
About this update from Alembic Pharmaceuticals Limited
[{"type":"text","content":" Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 09, 2023, titled \"Alembic Pharmaceuticals receives USFDA Tentative Approval for Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg.\". View Attachment","length":439,"tagName":"div"}]